SwishX, a Bengaluru-based startup backed by $2.2M in seed funding, launches the world's first agentic AI platform to modernise pharma and medtech sales, marketing, and distribution across a $400 billion emerging market opportunity.
A new one-time cell therapy, for HIV infection has shown promising results in a small early-stage study, raising hopes for a future where people living with HIV may not need lifelong daily medication. Researchers found that the experiment...
Biocon, Health Canada approval, and antifungal injection developments received a major boost after Biocon Pharma Ltd secured approval for Micafungin for Injection, strengthening the company’s presence in regulated international pharmaceuti...
India’s pharmaceutical sector witnessed major regulatory changes between May 4 and May 9 as the Central Drugs Standard Control Organisation (CDSCO) rolled out stricter compliance measures and accelerated approval reforms.
Abbott has launched its TriClip TEER system in India, bringing a new minimally invasive treatment option for patients suffering from tricuspid regurgitation, a serious heart valve disorder caused by a leaking tricuspid valve.
For decades, India’s role in pharma research was restricted to the role of a cost-effective destination for late-stage clinical trials. But now with Novartis, India will become the next pharma research capital.
AIIMS, affordable epilepsy test, and safer epilepsy treatment are now at the center of a major healthcare initiative aimed at improving treatment outcomes for patients across India. The new testing facility, introduced at the Neuroscienc...
Public Healthcare infrastructure in Delhi is set for a major expansion after the state government approved a Rs 805.99 crore medical college and hostel project in Dwarka. The upcoming facility, planned at the Indira Gandhi Hospital campus...
Lupin Q4 profit, US sales growth, and strong revenue momentum remained in focus after the pharmaceutical company reported an 87.7% jump in consolidated net profit to Rs 1,468.7 crore for the fourth quarter of FY2026. The impressive performan...
Chinese cancer drugs are bringing affordable relief to Indian patients as hospitals and pharmaceutical companies increasingly introduce lower-cost immunotherapy medicines into the country. The development is helping thousands of cancer pati...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")